Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fisons/Himedics deal

Executive Summary

Five Fisons products will be developed using Hollywood, Fla. based Himedics' delivery system for pediatric patients and others with difficulty swallowing. Licensing, supply and development agreement announced June 28. The products are: amoxicillin, erythromycin, acetaminophen, dicloxacillin and prednisone. Himedics' system processes drugs into taste-free microgranules that can be metered onto soft food for dosing. Fisons will hold exclusive rights to market and distribute the products in the U.S. in exchange for licensing fees totaling $ 3.5 mil. Himedics will develop and manufacture the products.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS017719

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel